Lv3
400 积分 2023-04-28 加入
From Rarity to Reality: Osimertinib's Promising Horizon in Treating Uncommon EGFR Mutations in Non-Small Cell Lung Cancer
2天前
已完结
A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer
24天前
已完结
Uncommon EGFR mutations in non-small-cell lung cancer: A systematic literature review of prevalence and clinical outcomes
24天前
已完结
The FDA’s latest draft guidance on accelerated approvals — one step forward, two steps back?
25天前
已完结
Detection of EGFR exon 20 insertion mutations in non-small cell lung cancer: implications for consistent nomenclature in precision medicine
1个月前
已完结
Reproducibility of c-Met Immunohistochemical Scoring (Clone SP44) for Non–Small Cell Lung Cancer Using Conventional Light Microscopy and Whole Slide Imaging
1个月前
已完结
Acquired resistance mechanisms to osimertinib: The constant battle
1个月前
已完结
Oncology Combination Dose‐Finding Study Design for Targeted and Immuno‐Oncology Therapies
1个月前
已完结
Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study
2个月前
已完结
Aluminum hypophosphite microencapsulated to improve its safety and application to flame retardant polyamide 6
4个月前
已完结
皖公网安备34019202002308
